Real world overall survival (OS) in patients with gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs) in a large United Kingdom (UK) tertiary centre

#3481

Introduction: The incidence and prevalence of GEP-NENs is rising worldwide. Overall survival (OS) data is mainly based on data from the USA SEER database. Little data exist regarding OS in a real world UK cohort. Existing data demonstrate no OS differences between gender.

Aim(s): To describe the real world OS of a large UK cohort of patients (pts) with GEP-NENs regardless any stage or treatment.

Materials and methods: A retrospective study on all pts recorded in our local database (2000-Sept 2021) with any type of GEP-NEN was performed. Additional data regarding, age, sex, grading and OS were collected. For OS the national database was checked on 6 Sept 2021. Kaplan Meier curves for survival analysis were performed and log rank test for statistical analysis.

Conference:

Presenting Author: Clement D

Authors: Clement D, Brown S, Halim M, Dolly S, Kibriya N,

Keywords: survival, gep-net, gender difference, neuroendocrine carcinoma,